-
1
-
-
0022905604
-
Results of the treatment of advanced-stage Burkitt's lymphoma and B cell (Sig+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine
-
S.B. Murphy, W.P. Bowman, and M. Abromowitch Results of the treatment of advanced-stage Burkitt's lymphoma and B cell (Sig+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine J Clin Oncol 4 1986 1732 1739
-
(1986)
J Clin Oncol
, vol.4
, pp. 1732-1739
-
-
Murphy, S.B.1
Bowman, W.P.2
Abromowitch, M.3
-
2
-
-
10044259800
-
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia
-
H. Kantarjian, D. Thomas, and S. O'Brien Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia Cancer 101 12 2004 2788 2801
-
(2004)
Cancer
, vol.101
, Issue.12
, pp. 2788-2801
-
-
Kantarjian, H.1
Thomas, D.2
O'Brien, S.3
-
3
-
-
4444268220
-
Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma
-
D.A. Thomas, S. O'Brien, and J. Cortes Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma Blood 104 6 2004 1624 1630
-
(2004)
Blood
, vol.104
, Issue.6
, pp. 1624-1630
-
-
Thomas, D.A.1
O'Brien, S.2
Cortes, J.3
-
4
-
-
0032422078
-
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma
-
I.F. Khouri, J. Romaguera, and H. Kantarjian Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma J Clin Oncol 16 12 1998 3803 3809
-
(1998)
J Clin Oncol
, vol.16
, Issue.12
, pp. 3803-3809
-
-
Khouri, I.F.1
Romaguera, J.2
Kantarjian, H.3
-
5
-
-
0034890433
-
Ovarian tissue cryopreservation for cancer patients: Who is appropriate?
-
J.F. Seymour Ovarian tissue cryopreservation for cancer patients: who is appropriate? Reprod Fertil Dev 13 2001 81 89
-
(2001)
Reprod Fertil Dev
, vol.13
, pp. 81-89
-
-
Seymour, J.F.1
-
6
-
-
0035009963
-
Long-term outcome of patients surviving for more than ten years following treatment for acute leukaemia
-
I.N. Micallef, A.Z. Rohatiner, and M. Carter Long-term outcome of patients surviving for more than ten years following treatment for acute leukaemia Br J Haematol 113 2 2001 443 445
-
(2001)
Br J Haematol
, vol.113
, Issue.2
, pp. 443-445
-
-
Micallef, I.N.1
Rohatiner, A.Z.2
Carter, M.3
-
7
-
-
25144512626
-
Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma
-
E.J. Dann, R. Epelbaum, and I. Avivi Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma Hum Reprod 20 8 2005 2247 2249 Epub 2005 Apr 7
-
(2005)
Hum Reprod
, vol.20
, Issue.8
, pp. 2247-2249
-
-
Dann, E.J.1
Epelbaum, R.2
Avivi, I.3
-
8
-
-
0027181005
-
Gonadal function after MACOP-B or VACOP-B with or without dose intensification and ABMT in young patients with aggressive non-Hodgkin's lymphoma
-
U. Muller, and R.A. Stahel Gonadal function after MACOP-B or VACOP-B with or without dose intensification and ABMT in young patients with aggressive non-Hodgkin's lymphoma Ann Oncol 4 5 1993 399 402
-
(1993)
Ann Oncol
, vol.4
, Issue.5
, pp. 399-402
-
-
Muller, U.1
Stahel, R.A.2
|